JP2018514208A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514208A5
JP2018514208A5 JP2017555766A JP2017555766A JP2018514208A5 JP 2018514208 A5 JP2018514208 A5 JP 2018514208A5 JP 2017555766 A JP2017555766 A JP 2017555766A JP 2017555766 A JP2017555766 A JP 2017555766A JP 2018514208 A5 JP2018514208 A5 JP 2018514208A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid construct
construct according
signal
intracellular retention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017555766A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018514208A (ja
JP6836515B2 (ja
Filing date
Publication date
Priority claimed from GBGB1507104.6A external-priority patent/GB201507104D0/en
Application filed filed Critical
Publication of JP2018514208A publication Critical patent/JP2018514208A/ja
Publication of JP2018514208A5 publication Critical patent/JP2018514208A5/ja
Application granted granted Critical
Publication of JP6836515B2 publication Critical patent/JP6836515B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017555766A 2015-04-27 2016-04-26 核酸構築物 Active JP6836515B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1507104.6 2015-04-27
GBGB1507104.6A GB201507104D0 (en) 2015-04-27 2015-04-27 Nucleic acid construct
PCT/GB2016/051164 WO2016174408A1 (en) 2015-04-27 2016-04-26 Nucleic acid construct

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020117039A Division JP2020171313A (ja) 2015-04-27 2020-07-07 核酸構築物

Publications (3)

Publication Number Publication Date
JP2018514208A JP2018514208A (ja) 2018-06-07
JP2018514208A5 true JP2018514208A5 (cg-RX-API-DMAC10.html) 2019-04-11
JP6836515B2 JP6836515B2 (ja) 2021-03-03

Family

ID=53488689

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017555766A Active JP6836515B2 (ja) 2015-04-27 2016-04-26 核酸構築物
JP2020117039A Withdrawn JP2020171313A (ja) 2015-04-27 2020-07-07 核酸構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020117039A Withdrawn JP2020171313A (ja) 2015-04-27 2020-07-07 核酸構築物

Country Status (10)

Country Link
US (1) US11530420B2 (cg-RX-API-DMAC10.html)
EP (1) EP3288968B1 (cg-RX-API-DMAC10.html)
JP (2) JP6836515B2 (cg-RX-API-DMAC10.html)
CN (1) CN107532176A (cg-RX-API-DMAC10.html)
AU (1) AU2016254498B2 (cg-RX-API-DMAC10.html)
CA (1) CA2984101A1 (cg-RX-API-DMAC10.html)
ES (1) ES2847698T3 (cg-RX-API-DMAC10.html)
GB (1) GB201507104D0 (cg-RX-API-DMAC10.html)
HK (1) HK1244021A1 (cg-RX-API-DMAC10.html)
WO (1) WO2016174408A1 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3805371A1 (en) 2014-05-15 2021-04-14 National University of Singapore Modified natural killer cells and uses thereof
GB201507108D0 (en) 2015-04-27 2015-06-10 Ucl Business Plc Nucleic acid construct
AU2016317936A1 (en) * 2015-09-04 2018-03-08 Tocagen Inc. Recombinant vectors comprising 2A peptide
CN118581046A (zh) 2016-11-22 2024-09-03 新加坡国立大学 用于t细胞恶性肿瘤免疫疗法的cd7表达阻滞剂和嵌合抗原受体
AU2018240556B2 (en) * 2017-03-24 2025-02-27 Lentigen Technology, Inc. Compositions and methods for treating cancer with anti-CD33 immunotherapy
MX2019011570A (es) 2017-03-27 2019-11-18 Nat Univ Singapore Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales.
CN117363636A (zh) 2017-03-27 2024-01-09 新加坡国立大学 一种编码嵌合受体的多核苷酸
WO2019081750A1 (en) * 2017-10-27 2019-05-02 Statens Serum Institut VACCINE AGAINST POLYGENIC INFLUENZA
CN108359014A (zh) * 2018-02-08 2018-08-03 四川农业大学 含有dhav-1 2a1-p的多肽及其介导的多蛋白共表达方法
JP7360174B2 (ja) 2018-02-09 2023-10-12 ナショナル ユニヴァーシティー オブ シンガポール ナチュラルキラー細胞免疫療法における活性化キメラ受容体及びその使用
US12441787B2 (en) 2018-04-02 2025-10-14 National University Of Singapore Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
GB201805918D0 (en) 2018-04-10 2018-05-23 Autolus Ltd Cell
EP3841116A4 (en) * 2018-08-24 2022-05-25 Locanabio, Inc. FASL IMMUNOMODULATING GENE THERAPY COMPOSITIONS AND METHODS OF USE
WO2020044239A1 (en) 2018-08-29 2020-03-05 National University Of Singapore A method to specifically stimulate survival and expansion of genetically-modified immune cells
CN113226340A (zh) 2018-11-26 2021-08-06 恩卡尔塔公司 同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途
KR20210137085A (ko) 2019-03-05 2021-11-17 엔카르타, 인크. Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
GB201914611D0 (en) * 2019-10-09 2019-11-20 Autolus Ltd Engineered immune cell
WO2024197792A1 (en) * 2023-03-31 2024-10-03 Beijing University Of Chinese Medicine A complex comprising a cell penetrating peptide and a copi sorting inhibitor and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503260A (ja) * 1996-10-23 2001-03-13 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 改良されたワクチン
CN101595228A (zh) * 2005-07-21 2009-12-02 艾博特公司 包括sorf构建体的多基因表达和使用多蛋白、前体蛋白和蛋白酶解的方法
CN103483452B (zh) * 2012-06-12 2021-08-13 上海细胞治疗集团有限公司 双信号独立的嵌合抗原受体及其用途
EP2922866B1 (en) 2012-11-21 2019-01-23 Merz Pharma GmbH & Co. KGaA Means and methods for determination of botulinum neurotoxin biological activity
EP3104866A4 (en) * 2014-02-14 2017-08-02 Bellicum Pharmaceuticals, Inc. Methods for activating t cells using an inducible chimeric polypeptide
EA037575B1 (ru) 2015-01-26 2021-04-15 Юнайтед Стейтс Минерал Продактс Компани Коррозионно-стойкие напыляемые огнестойкие материалы

Similar Documents

Publication Publication Date Title
JP2018514209A5 (cg-RX-API-DMAC10.html)
Fujii et al. PA tag: A versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin
JP6836515B2 (ja) 核酸構築物
JP2016533174A5 (cg-RX-API-DMAC10.html)
ZA202006432B (en) T cell receptors
WO2011039508A3 (en) T-cell receptor
JP7704685B2 (ja) 抗原結合タンパク質
IL274547B1 (en) Modified ligand-gated ion channels and methods of use
JP2019521643A5 (cg-RX-API-DMAC10.html)
Tang et al. Molecular cloning and localization of human syntaxin 16, a member of the syntaxin family of SNARE proteins
HRP20220080T1 (hr) Poboljšane imunoglobulinske varijabilne domene koje vežu serumski albumin
FI3527070T3 (fi) Humanisoituja kevytketjuhiiriä
Carrington et al. Sequence and expression of the glycosyl-phosphatidylinositol-specific phospholipase C of Trypanosoma brucei
JP2019535268A5 (ja) アクチビンIIa型受容体変異体および同変異体を含む医薬組成物
WO2011112089A3 (en) Mutated rep encoding sequences for use in aav production
JP2018530315A5 (cg-RX-API-DMAC10.html)
WO2008138649A3 (en) Signaling peptides
WO2020120982A3 (en) Cell
Demirel et al. Tuning the cellular trafficking of the lysosomal peptide transporter TAPL by its N‐terminal domain
Nogi et al. Novel affinity tag system using structurally defined antibody‐tag interaction: application to single‐step protein purification
Yant et al. Identification of a cytoplasmic Tyr-XX-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection
JP2015527074A5 (cg-RX-API-DMAC10.html)
Forti et al. Identification of a novel overlapping sequential E epitope (E′) on the bovine leukaemia virus SU glycoprotein and analysis of immunological data
Jun et al. D‐AKAP 1a is a signal‐anchored protein in the mitochondrial outer membrane
WO2009002939A3 (en) Autophilic antibodies